PTCT logo

PTC Therapeutics (PTCT) Current Liabilities

Annual Current Liabilities

$603.10 M
+$196.86 M+48.46%

31 December 2023

PTCT Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$610.71 M
+$909.00 K+0.15%

30 September 2024

PTCT Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PTCT Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+48.5%+24.1%
3 y3 years+117.5%+31.3%
5 y5 years+261.6%+232.8%

PTCT Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+117.5%at high+50.3%
5 y5 yearsat high+261.6%at high+232.8%
alltimeall timeat high+4491.9%at high+6510.1%

PTC Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$610.71 M(+0.1%)
June 2024
-
$609.80 M(+6.1%)
Mar 2024
-
$574.55 M(-4.7%)
Dec 2023
$603.10 M(+48.5%)
$603.10 M(+22.6%)
Sept 2023
-
$492.12 M(+3.3%)
June 2023
-
$476.34 M(+7.9%)
Mar 2023
-
$441.63 M(+8.7%)
Dec 2022
$406.24 M(-20.2%)
$406.24 M(-3.3%)
Sept 2022
-
$420.08 M(-26.0%)
June 2022
-
$567.37 M(+19.0%)
Mar 2022
-
$476.78 M(-6.4%)
Dec 2021
$509.35 M(+83.7%)
$509.35 M(+9.5%)
Sept 2021
-
$465.26 M(+59.9%)
June 2021
-
$290.96 M(+15.9%)
Mar 2021
-
$250.95 M(-9.5%)
Dec 2020
$277.33 M(+17.6%)
$277.33 M(+9.3%)
Sept 2020
-
$253.82 M(+25.8%)
June 2020
-
$201.84 M(-7.3%)
Mar 2020
-
$217.67 M(-7.7%)
Dec 2019
$235.86 M(+41.4%)
$235.86 M(+28.5%)
Sept 2019
-
$183.50 M(+5.5%)
June 2019
-
$173.96 M(+21.6%)
Mar 2019
-
$143.05 M(-14.2%)
Dec 2018
$166.80 M
$166.80 M(+45.1%)
DateAnnualQuarterly
Sept 2018
-
$114.92 M(+32.9%)
June 2018
-
$86.47 M(+18.9%)
Mar 2018
-
$72.72 M(-11.4%)
Dec 2017
$82.05 M(+65.3%)
$82.05 M(+14.1%)
Sept 2017
-
$71.90 M(+5.8%)
June 2017
-
$67.98 M(+49.7%)
Mar 2017
-
$45.42 M(-8.5%)
Dec 2016
$49.62 M(+9.3%)
$49.62 M(+1.4%)
Sept 2016
-
$48.93 M(+14.0%)
June 2016
-
$42.91 M(-2.2%)
Mar 2016
-
$43.89 M(-3.3%)
Dec 2015
$45.39 M(+39.8%)
$45.39 M(+43.2%)
Sept 2015
-
$31.70 M(+37.3%)
June 2015
-
$23.08 M(-3.4%)
Mar 2015
-
$23.91 M(-26.4%)
Dec 2014
$32.48 M(+147.3%)
$32.48 M(+88.1%)
Sept 2014
-
$17.26 M(+49.0%)
June 2014
-
$11.58 M(+25.4%)
Mar 2014
-
$9.24 M(-29.7%)
Dec 2013
$13.13 M(-53.4%)
$13.13 M(-5.7%)
Sept 2013
-
$13.92 M(-29.7%)
June 2013
-
$19.79 M(-27.6%)
Mar 2013
-
$27.33 M(-3.0%)
Dec 2012
$28.16 M(-34.7%)
$28.16 M
Dec 2011
$43.15 M
-

FAQ

  • What is PTC Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for PTC Therapeutics?
  • What is PTC Therapeutics annual current liabilities year-on-year change?
  • What is PTC Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for PTC Therapeutics?
  • What is PTC Therapeutics quarterly current liabilities year-on-year change?

What is PTC Therapeutics annual total current liabilities?

The current annual current liabilities of PTCT is $603.10 M

What is the all time high annual current liabilities for PTC Therapeutics?

PTC Therapeutics all-time high annual total current liabilities is $603.10 M

What is PTC Therapeutics annual current liabilities year-on-year change?

Over the past year, PTCT annual total current liabilities has changed by +$196.86 M (+48.46%)

What is PTC Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of PTCT is $610.71 M

What is the all time high quarterly current liabilities for PTC Therapeutics?

PTC Therapeutics all-time high quarterly total current liabilities is $610.71 M

What is PTC Therapeutics quarterly current liabilities year-on-year change?

Over the past year, PTCT quarterly total current liabilities has changed by +$118.59 M (+24.10%)